Back to News
Market Impact: 0.2
OpenAI acquires startup Orchestra Bio to beef up its biotech business
Source: TechCrunch
Artificial IntelligenceHealthcare & BiotechTechnology & Innovation
OpenAI says it is adding Orchestra’s team and technology to work on Rosalind, its AI model for life sciences research, and Rosalind Workbench. The tool is designed to help researchers plan experiments and analyze results; no financial terms or expected commercial impact were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- Elon Musk says SpaceX and Tesla exploring largest merger in history
- Asia stocks rebound as SpaceX, Super Micro results lift chipmakers
- Neoclouds Lose Silver Lining as Elice, CoreWeave Dive: Evening Briefing Americas
- Anthropic May Spend $750 Billion on Computing Costs, WSJ Reports
- This Janus Henderson fund manager owns CoreWeave debt — here's why he's sticking with it
- ‘I don’t care how it’s done’: Trump pressures Ukraine to cut peace deal